Physician profile
Paul Lively
NPI 1548212749
$583.09
in general payments reported to CMS, 2019-2025
17 companies · $76.29 in 2025
The $76.29 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.53 · 2020: $94.37 · 2021: $68.94 · 2022: $61.79 · 2023: $206 · 2024: $46.00 · 2025: $76.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $328.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $99.56 | 2021-2025 | Vaxneuvance, Gardasil 9, Rotateq |
| Tris Pharma INC | $92.05 | 2020-2022 | |
| Corium, LLC | $51.82 | 2023 | Azstarys |
| Supernus Pharmaceuticals, INC. | $48.99 | 2023-2025 | Qelbree, Qelbree |
| Astrazeneca Pharmaceuticals LP | $34.73 | 2023 | Flumist Quadrivalent |
| Ironshore Pharmaceuticals INC. | $29.53 | 2019 | |
| Pfizer INC. | $28.07 | 2024-2025 | |
| Adlon Therapeutics L.P. | $27.61 | 2020 | |
| Arbor Pharmaceuticals, INC. | $26.18 | 2020 | |
| Cranial Technologies, INC | $25.90 | 2023 | Doc Band |
| Genzyme Corporation | $24.91 | 2023 | |
| Neurelis, INC. | $23.63 | 2023 | Valtoco |
| Noven Therapeutics, LLC | $16.63 | 2024 | Xelstrym |
| Vertical Pharmaceuticals, LLC | $15.22 | 2025 | Relexxii |
| Seqirus USA INC | $12.96 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $12.80 | 2022 | |
| Glaxosmithkline, LLC. | $12.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Lively listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.